Conference Coverage

Reports from professional meetings related to sarcoma.
Particle Therapy for Sarcomas
Presenter: T. DelaneyPresenter's Affiliation: Massachusetts General Hospital, Boston, MAType of Session: ScientificBackground Sarcomas of bone and soft tissues represent only 1% of adult malignancies. They generally require multidisciplinary treatment, with ..
Use of Particle Therapy in Treatment of Sarcomas
Presenter: Eugen Hug, M.D.Presenter's Affiliation: Paul Scherrer InstituteType of Session: Scientific Introduction Dr. Eugen Hug initiated his discussion of the indications for particle based radiotherapy in treatment of sarcomas by ..
Proton Radiotherapy for Cardiac and Pulmonary Vessel Sarcomas
Presenter: Dr. Yen-Lin Chen Presenter's Affiliation: Massachusetts General Hospital, Radiation Oncology, Boston Background Although cardiac and pulmonary vessel sarcomas are rare, they are not unheard of, and pose significant treatment ..
Sarcoma: Self-Reported Functional Outcomes and Quality of Life Assessments in Long-Term Survivors of Ewing Sarcoma
Presenting Author: Dr. Bradley Stish Presenting Author Affiliation: Mayo Clinic Ewing sarcoma is a rare soft tissue malignancy that typically affects the bones and soft tissue and is most common ..
Neoadjuvant Chemotherapy and Radiotherapy for Large Extremity Soft Tissue Sarcomas
Presenter: T.F. DeLaney Presenter's Affiliation: Massachusetts General Hospital, Boston, MA Type of Session: Scientific Background The management of extremity soft tissue sarcomas has evolved from amputation to limb sparing surgery ..
Phase II Study of Proton Radiotherapy for Spine and Paraspinal Sarcoma
Presenter: Thomas F. DelaneyPresenter's Affiliation: Massachusetts General Hospital, Boston, MAType of Session: ScientificBackground Sarcomas located in the spinal axis have a poor prognosis, as local control of the disease is ..
Preliminary Experience with Proton Radiotherapy for Pelvic Bone Sarcomas
Presenter: T. DelaneyPresenter's Affiliation: Massachusetts General HospitalType of Session: ScientificBackground Surgery is commonly used for the definitive treatment of pelvic bone sarcomas. However, acceptable surgical margins are difficult to achieve ..
Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas
Presenter: Dr. Tadashi KamadaPresenter's Affiliation: Research Center for Charged Particle Therapy, Chiba, JapanType of Session: ScientificBackground The results from a phase I/II dose escalation study using carbon ion therapy in ..
High Dose Proton Therapy for Soft Tissue Sarcoma of Trunk Type of Session: Scientific Session
Presenter: Hiroshi Fuji Presenter's Institution: Shizuoka Cancer Center, Japan Background Soft tissue sarcomas are a group of tumors that originate from muscle, fat, and tendons. Soft tissue sarcomas are a ..
Long-Term Follow-Up on Phase II Study of High-Dose Proton/Photon Radiotherapy for Spine Sarcomas
Presenting Author/Institution: Thomas DeLaney, MD/Massachusetts General Hospital Background The primary treatment of tumors of the spine and paraspinal tissues is challenging; surgical resection is the mainstay of treatment but negative ..
Patients Self-Administer Protein in Nose Drops to Treat Kaposi's Sarcoma
An anti-angiogenesis and immune-stimulating protein, delivered via nose drops, has resulted in a complete or major response in more than one-third of patients with late-stage Kaposi's Sarcoma (KS), an AIDS-related ..
Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vascualture
Presenter: James Murphy, MDPresenter's Affiliation: University of MichiganType of Session: ScientificBackground Rapamycin is an FDA approved immunosuppressant used in organ transplant, especially renal. It was derived from a soil sample from ..
Particle Therapy for Bone and Soft Tissue Sarcomas: A Retrospective Study
Presenter: Y. Demizu , M. Murakami, D. Miyawaki, M. Mima, K. Terashima, T. Arimura, Y. Niwa, Y. Hishikawa Presenter's Affiliation: Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, JapanType ..
Proton Radiotherapy for Pediatric Ewing's Sarcomas: Initial Clinical Outcomes of 29 Patients
Presenter: B. RombiPresenter's Affiliation: Trento, ItalyType of Session: ScientificBackground Ewing’s sarcoma represents the second most common bone tumor in children; the Ewing’s family of tumors includes osseous Ewing’s sarcoma, extraosseous ..
Response to neoadjuvant thermochemotherapy as significant prognosticator for long-term survival of patients with retroperitoneal or visceral high-risk soft-tissue sarcoma
Presenter: C.M.Wendtner Affiliation: Ludwig-Maximilian-University Background: The clinical application of hyperthermia with increase of tissue temperatures (range 40-44 degrees C) has been integrated in multimodal anti- cancer strategies. The combination of ..
Neoadjuvant chemotherapy for primary high grade extremity soft tissue sarcoma: A matched case control study
Presenter: S. R. GrobmyerPresenter's Affiliation: Memorial Sloan-Kettering Cancer Center and Dana-Farber Cancer InstituteType of Session: ScientificBackground The investigation of high grade (HG) extremity soft tissue sarcomas (STS) is often challenging ..
Outcome of clear cell sarcoma of the kidney (CCSK) treated on the National Wilms Tumor Study-5 (NWTS)
Presenter: Breslow EJ et al.Presenter's Affiliation: Children's National Medical Center, Washington D.C.Type of Session: ScientificBackground CCSK originally described in early 1970s and characterized by tendency to metastasize to bone as ..
Patient Summary: Outcome of clear cell sarcoma of the kidney (CCSK) treated on the National Wilms Tumor Study-5 (NWTS)
Outcome of clear cell sarcoma of the kidney (CCSK) treated on the National Wilms Tumor Study-5 (NWTS) Clear cell sarcoma of the kidney was first described in the 1970's and ..
A Comparison of 3-D Conformal Proton Therapy, Intensity Modulated Proton Therapy, and Intensity Modulated Photon Therapy for Retroperitoneal Sarcoma
Presenter: Christine S. ChungPresenter's Affiliation: Harvard Radiation Oncology Program, Boston, MAType of Session: ScientificBackground The treatment of retroperitoneal sarcoma usually involves a combination of surgery and radiotherapy. Post-operative radiotherapy can ..
Percent Necrosis in Extremity Soft Tissue Sarcoma After Preoperative Radiation Alone Versus Preoperative Radiation and Chemotherapy
Presenter: Karl Haglund MD, PhDPresenter's Affiliation: Massachusetts General HospitalType of Session: ScientificBackground Prior studies have found that treatment related necrosis is a prognostic marker in bone sarcomas. Retrospective studies of ..
Proton beam therapy for bone and soft tissue sarcomas: 35-year single institutional retrospective review
Presenter: S. Goldberg Affiliation: Harvard Medical School, Mass General Hospital, Boston, MA Other Authors: A. Agarwal, T. DeLaney, M. Niemerko, A. Niemerko, H. Suit Background Bone and soft tissue extremity ..
Results of a Prospective Study Delivering Limited Margin Radiotherapy for Pediatric Patients with Ewing’s Sarcoma Family of Tumors
Presenter: M.J. KrasinPresenter's Affiliation: St. Jude Children’s Research Hospital, Memphis, TNType of Session: ScientificBackground The Ewing’s sarcoma represents the 2nd most common bone tumor in children, following osteosarcoma. The Ewing’s sarcoma ..

Bevacizumab Active in HIV-Linked Kaposi's Sarcoma

Mar 20, 2012 - For patients with HIV-associated Kaposi's sarcoma, bevacizumab is tolerated and induces a response in some patients, according to a study published online March 19 in the Journal of Clinical Oncology.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More